Considering that activation of B1 receptor triggers pro-inflammatory responses36, 37, we believe that the lower levels of IL-10 in primary tumors from WT animals might be due to the pro-inflammatory action of the WT host B1 receptor, which in this case can counteract the anti-inflammatory response within the tumor. The gene discussed is IL10; the disease is neoplasm.